989
Participants
Start Date
November 30, 2006
Primary Completion Date
June 30, 2012
Study Completion Date
January 31, 2014
Insulin
Study drug is continuously infused intravenous insulin. Suggested dose is calculated by a computerized infusion algorithm using the participant's blood sugar concentration. The insulin infusion rate is titrated to maintain normal blood sugar. Participants are eligible to receive insulin while they have an in-dwelling arterial catheter.
Usual Care
Participants receive standard Cardiac ICU care without tight blood glucose control.
C.S. Mott Children's Hospital, Ann Arbor
Children's Hospital Boston, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Boston Children's Hospital
OTHER